Montreal, Sept. 17 -- Spinal cerebellar ataxia 6 (SCA6) is a hereditary neurological disease that impairs motor coordination. Because SCA6 affects only about one in 100,000 people, medical researchers have paid it little attention. There is currently no known cure and just a few therapeutic alternatives.

The findings of the study "Activation of TrkB - Akt signaling rescues deficits in a mouse model of SCA6" by Anna Cook et al. was published in Science Advances.

Now, a team of McGill University researchers specializing in SCA6 and other forms of ataxia, have published findings that not only offer hope for SCA6 sufferers but may also open the way to developing treatments for other movement disorders.

Exercise in a pill

In mice affected by...